Specification :

Raloxifene 84449-90-1

Formula C28H27NO4S
Mol. mass 473.584 g/mol

Raloxifene is indicated for the treatment and prevention of osteoporosis in postmenopausal women,
for reduction in risk of invasive breast cancer in postmenopausal women with osteoporosis, and for reduction in risk of invasive breast cancer in postmenopau